NOV 15, 2018 03:00 PM CET
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

HDV, the most severe form of viral hepatitis. What you need to know about it

SPONSORED BY: DiaSorin
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Associate Professor of Virology at the Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Italy
    Biography
      Valentina Svicher is an Associate Professor of Virology at the Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata". She got a degree cum laude in Biological Sciences in 2001 and a PhD in Microbiology and Immunology in 2006. Her research interests and expertise are focused on mechanisms underlying pathogenesis and response to therapy in the setting of chronic viral infections with particular attention on hepatitis B and D virus.
      She is author of more than 90 full papers in peer-reviewed journals, and more than 250 papers presented at numerous National and International Conferences. She received several awards such as "GB Rossi" Scientific Prize 2009, "Readfiles" Scientific Award 2008 and the Scientific Award "Infection Lab 2016" for the best scientific publications or projects in the infectivology field.
      She collaborates with many nationally and internationally recognized scientific researchers through grants from the Italian National Institute of Health, the Ministry of University and Scientific Research, the European Community and Industrial Companies.
      She is member of the Board of the Scientific Society "European Society for Antiviral Research (ESAR); Member of the HCV Italian Resistance Network Study Group; Member of the European HepCare group; Member of the Italian Study Group on the treatment and prophylaxis of HBV in the haematological patients.
    • Head of the Hepatitis Unit at the Spanish National Center of Microbiology, Istituto de Salud Carlos III Madrid, Spain
      Biography
        Medical Doctor and PhD, has more than 20 years of experience in the Virology field, being the Head of the Hepatitis Unit at the Spanish National Center of Microbiology since 2010. Her responsibilities extent to hepatitis viruses reference and surveillance activities, including confirmation of diagnosis and characterization. Currently she participates as an expert in ECDC hepatitis B & C group and in ECDC hepatitis E group.

      Abstract:
      DATE: November 15, 2018
      TIME: 06:00am EDT, 09:00am EDT, 3:00pm CET
       
      Part 1 - Presented by Valentina Svicher
       
      Hepatitis Delta Virus: insights and emerging concepts into a peculiar pathogen
      Hepatitis D virus (HDV) is a unique RNA virus that requires the hepatitis B surface antigen (HBsAg) to infect the hepatocytes. Chronic Hepatitis D is recognized as the most severe form of viral hepatitis, leading to accelerated progression of cirrhosis and hepatocellular carcinoma and a high mortality rate. HDV infection affects an estimated 15–20 million individuals, is spread worldwide and is endemic in some regions. Moreover, HDV prevalence is increasing in many countries as a consequence of immigration from highly endemic geographic areas.
       
      Despite the severity of hepatitis D, screening and treatment has been often neglected in part due to the lack of an effective therapy.  Indeed, interferon alpha is the only anti-HDV drug approved for the treatment of chronic hepatitis D, even if its efficacy is limited and side effects can be severe. Future therapeutic options are under investigation targeting HDV entry, HBsAg secretion, and viral assembly. This webinar will summarize current knowledge on virological and epidemiological aspects of HDV infection with particular attention of categories of individuals in which HDV testing should be prioritized. It also provides an overview on the upcoming treatment options against this virus.
       
      Learning Objectives:
      • Discuss epidemiological and virological aspects of HDV infection
      • Identify categories of individuals at risk of acquiring HDV infection
      • Describe current and future HDV treatments
       
       
      Part 2 - Presented by Ana Avellon
       
      HDV infection: how and when to diagnose a forgotten disease 
      Although the most aggressive infectious liver disease, hepatitis delta virus (HDV) infection may be underdiagnosed both for the unawareness or the unavailability of accurate diagnostic methods. Any hepatitis B virus (HBV) infected patient is susceptible to HDV infection for life and consequently searching for HDV should be included in HBV infected patient monitoring guidelines. Periodically detection of HDV antibody and viral RNA in HBV infected patients can early diagnose HDV and may impact the progress of the liver disease.
       
      Learning Objectives:
      • How to diagnose HDV: methods and interpretation of results
      • When to ask for HDV diagnosis: guidelines review

      Show Resources
      You May Also Like
      MAY 24, 2018 09:30 AM PDT
      C.E. CREDITS
      MAY 24, 2018 09:30 AM PDT
      DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
      AUG 15, 2018 08:00 AM PDT
      C.E. CREDITS
      AUG 15, 2018 08:00 AM PDT
      DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
      MAY 22, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 22, 2018 08:00 AM PDT
      DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
      APR 27, 2018 10:00 AM PDT
      C.E. CREDITS
      APR 27, 2018 10:00 AM PDT
      DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
      JUN 26, 2018 06:00 AM PDT
      C.E. CREDITS
      JUN 26, 2018 06:00 AM PDT
      Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
      MAY 02, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 02, 2018 08:00 AM PDT
      Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
      Loading Comments...